Dr. Critchfield
Chairman
Oncology
Shuwen Biotech
China
Biography
Dr. Critchfield currently is Chairman, President and CEO of Sera Prognostics Inc. He retired as president and board member of Myriad Genetic Laboratories in March 2010. As head of Myriad’s diagnostic company for 12 years, Dr. Critchfield launched seven novel molecular diagnostic products across a variety of technology platforms and grew annual revenues from $2.2 million to $326.5 million. Prior to Myriad, he served as senior vice president, chief medical and science officer at Corning Clinical Laboratories/Quest Diagnostics. Dr. Critchfield currently serves on the boards of Integrated Diagnostics, Saladax Biomedical, Nodality, and Metamark Genetics. He holds a B.S. in Microbiology from BYU, an M.D. from the University of Utah College of Medicine, and an M.S. in Biophysical Sciences from the University of Minnesota.
Research Interest
oncology
